Most investors are familiar with SEC forms 8-K, 10-Q and 10-K. However, one supplemental filing form not nearly as common is a confidential treatment request. A CTR is a request made by a company that the SEC omit certain information required to be filed from the company’s public SEC filing documents. Once a company files a CTR, the SEC’s ruling on the request will be contained in a confidential treatment order.

According to the SEC, only very specific types of information can be kept confidential: “A registrant can request confidential treatment for information, the disclosure of which could adversely affect the company’s business and financial condition, usually because of the competitive harm that could result from such disclosure.”

The SEC names pricing terms, technical specifications and milestone payments as three examples of non-public information that are commonly granted protection under CTOs. CTOs are temporary, and the company requesting the CTO must specify the date on which the CTO will expire.

Example

Just this week, Intercept Pharmaceuticals Inc ICPT 0.17% was granted…

Click here to continue reading

Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common Sense. I don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!